Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis

AIM: Fuzhenghuayu (FZHY) capsule can inhibit the progression of cirrhosis. This study explored whether FZHY can reduce the incidence of hepatocellular carcinoma (HCC) in patients with hepatitis B-caused cirrhosis (HBC) undergoing antiviral therapy. METHODS: A retrospective review of 842 patients wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evid Based Complement Alternat Med
Main Authors: Shi, Ke, Liu, Yao, Wang, Xiaojing, Li, Yuxin, Zhang, Qun, Hu, Ying, Ran, Chongping, Huang, Yunyi, Hou, Jie, Wang, Xianbo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7644307/
https://ncbi.nlm.nih.gov/pubmed/33178324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8826091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados